Assessing Quality-of-Life of Patients Taking Mirabegron for Overactive Bladder
Christina Shaw,1 William Gibson2 1Division of Geriatric Medicine, University of British Columbia, Vancouver, British Columbia, Canada; 2Division of Geriatric Medicine, University of Alberta, Edmonton, Alberta, CanadaCorrespondence: William Gibson, Division of Geriatric Medicine, University of Albert...
Main Authors: | Shaw C, Gibson W |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2023-01-01
|
Series: | Therapeutics and Clinical Risk Management |
Subjects: | |
Online Access: | https://www.dovepress.com/assessing-quality-of-life-of-patients-taking-mirabegron-for-overactive-peer-reviewed-fulltext-article-TCRM |
Similar Items
-
Mirabegron: A first-in-class beta-3 agonist for overactive bladder
by: Suruchi Aditya, et al.
Published: (2015-01-01) -
Mirabegron in the Treatment of Overactive Bladder: Safety and Efficacy in the Very Elderly Patient
by: Makhani A, et al.
Published: (2020-04-01) -
Mirabegron in the Management of Overactive Bladder Syndrome
by: O'Kane M, et al.
Published: (2022-09-01) -
Comparative Study Between Behavior Therapy and Behavior Therapy Plus Mirabegron 50 mg in Sexually Active Men With Bothersome Overactive Bladder Symptoms – A Multicenter, Randomized Study
by: Chih-Chieh Lin, et al.
Published: (2023-09-01) -
Patient utilization survey of mirabegron prescribed for overactive bladder
by: Päivi Rahkola-Soisalo, et al.
Published: (2019-03-01)